133 related articles for article (PubMed ID: 1479202)
1. Quantitative estimation of the thermal dose-modifying factor for cis-diamminedichloroplatinum (CDDP) in tumour-bearing dogs.
Page RL; Thrall DE; George SL; Price GS; Heidner GL; McEntee MC; Novotney CA; Hauck ML; Dewhirst MW
Int J Hyperthermia; 1992; 8(6):761-9. PubMed ID: 1479202
[TBL] [Abstract][Full Text] [Related]
2. Effect of whole body hyperthermia on carboplatin disposition and toxicity in dogs.
Page RL; McEntee MC; Williams PL; George SL; Price GS; Novotney CA; Hauck ML; Riviere JE; Dewhirst MW; Thrall DE
Int J Hyperthermia; 1994; 10(6):807-16. PubMed ID: 7884240
[TBL] [Abstract][Full Text] [Related]
3. Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
Ohno S; Strebel FR; Stephens LC; Siddik ZH; Makino M; Klostergaard J; Tomasovic SP; Khokhar AR; Bull JM
Cancer Res; 1992 Aug; 52(15):4096-101. PubMed ID: 1638521
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of melphalan alone and melphalan plus whole body hyperthermia in dogs with malignant melanoma.
Page RL; Thrall DE; Dewhirst MW; Macy DW; George SL; McEntee MC; Heidner GL; Novotney CA; Allen SA; Withrow SJ
Int J Hyperthermia; 1991; 7(4):559-66. PubMed ID: 1919151
[TBL] [Abstract][Full Text] [Related]
5. Phase I evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma.
Novotney CA; Page RL; Macy DW; Dewhirst MW; Ogilvie GK; Withrow SJ; McEntee MC; Heidner GL; Allen SA; Thrall DE
J Vet Intern Med; 1992; 6(4):245-9. PubMed ID: 1522556
[TBL] [Abstract][Full Text] [Related]
6. Phase I evaluation of mitoxantrone alone and combined with whole body hyperthermia in dogs with lymphoma.
Hauck ML; Price GS; Ogilvie GK; Johnson J; Gillette EL; Thrall DE; Dewhirst MW; Page RL
Int J Hyperthermia; 1996; 12(3):309-20. PubMed ID: 9044901
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinoma.
Toyota N; Strebel FR; Stephens LC; Matsuda H; Oshiro T; Jenkins GN; Bull JM
Int J Cancer; 1998 May; 76(4):499-505. PubMed ID: 9590125
[TBL] [Abstract][Full Text] [Related]
8. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
Ohno S; Siddik ZH; Baba H; Stephens LC; Strebel FR; Wondergem J; Khokhar AR; Bull JM
Cancer Res; 1991 Jun; 51(11):2994-3000. PubMed ID: 2032236
[TBL] [Abstract][Full Text] [Related]
9. Interaction of cis-diamminedichloro-platinum(II) and its analogues cis-1,1- cyclobutanedicarboxylato(2R)-2-methyl-1,4-butanediammineplatinum(II) and cis-diammine(glycolato)platinum with hyperthermia in vivo.
Takahashi I; Maehara Y; Kusumoto H; Kusumoto T; Baba H; Kohnoe S; Sugimachi K
Oncology; 1996; 53(1):68-72. PubMed ID: 8570136
[TBL] [Abstract][Full Text] [Related]
10. Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients.
Robins HI; Cohen JD; Schmitt CL; Tutsch KD; Feierabend C; Arzoomanian RZ; Alberti D; d'Oleire F; Longo W; Heiss C
J Clin Oncol; 1993 Sep; 11(9):1787-94. PubMed ID: 8355046
[TBL] [Abstract][Full Text] [Related]
11. Absence of whole body hyperthermia effect on cisplatin distribution in spontaneous canine tumors.
Page RL; Lee J; Riviere JE; Dodge RK; Thrall DE; Dewhirst MW
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1097-102. PubMed ID: 7607930
[TBL] [Abstract][Full Text] [Related]
12. Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma.
Page RL; Macy DW; Ogilvie GK; Rosner GL; Dewhirst MW; Thrall DE; Withrow SJ; McEntee MC; Cline JM; Heidner GL
Int J Hyperthermia; 1992; 8(2):187-97. PubMed ID: 1573308
[TBL] [Abstract][Full Text] [Related]
13. A comparison of temperatures in canine solid tumours during local and whole-body hyperthermia administered alone and simultaneously.
Thrall DE; Dewhirst MW; Page RL; Samulski TV; McLeod DA; Oleson JR
Int J Hyperthermia; 1990; 6(2):305-17. PubMed ID: 2324571
[TBL] [Abstract][Full Text] [Related]
14. Effect of altered duration of 41.5 degrees C whole body hyperthermia in combination with cis-diamminedichloroplatinum (II) on tumor and normal tissue apoptosis and tumor response in rats.
Toyota N; Strebel FR; Stephens LC; Rowe W; Matsuda H; Oshiro T; Jenkins GN; Bull JM
Oncol Rep; 1998; 5(5):1231-6. PubMed ID: 9683841
[TBL] [Abstract][Full Text] [Related]
15. Use of whole body hyperthermia as a method to heat inaccessible tumours uniformly: a phase III trial in canine brain masses.
Thrall DE; Larue SM; Powers BE; Page RL; Johnson J; George SL; Kornegay JN; McEntee MC; Levesque DC; Smith M; Case BC; Dewhirst MW; Gillette EL
Int J Hyperthermia; 1999; 15(5):383-98. PubMed ID: 10519690
[TBL] [Abstract][Full Text] [Related]
16. Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients.
Robins HI; Rushing D; Kutz M; Tutsch KD; Tiggelaar CL; Paul D; Spriggs D; Kraemer C; Gillis W; Feierabend C; Arzoomanian RZ; Longo W; Alberti D; d'Oleire F; Qu RP; Wilding G; Stewart JA
J Clin Oncol; 1997 Jan; 15(1):158-64. PubMed ID: 8996137
[TBL] [Abstract][Full Text] [Related]
17. Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas.
Thrall DE; Prescott DM; Samulski TV; Rosner GL; Denman DL; Legorreta RL; Dodge RK; Page RL; Cline JM; Lee J; Case BC; Evans SM; Oleson JR; Dewhirst MW
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1087-96. PubMed ID: 8600092
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma.
Wiedemann GJ; d'Oleire F; Knop E; Eleftheriadis S; Bucsky P; Feddersen S; Klouche M; Geisler J; Mentzel M; Schmucker P
Cancer Res; 1994 Oct; 54(20):5346-50. PubMed ID: 7923163
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
Robins HI; Katschinski DM; Longo W; Grosen E; Wilding G; Gillis W; Kraemer C; Tiggelaar CL; Rushing D; Stewart JA; Spriggs D; Love R; Arzoomanian RZ; Feierabend C; Alberti D; Morgan K; Simon K; d'Oleire F
Cancer Chemother Pharmacol; 1999; 43(5):409-14. PubMed ID: 10100597
[TBL] [Abstract][Full Text] [Related]
20. Whole-body hyperthermia combined with hyperfractionated irradiation of the thorax in dog: acute physiological response.
McChesney Gillette S; Dawson CA; Scott RJ; Rickaby DA; Powers BE; Johnston MR; Chen C; Gillette EL
Int J Hyperthermia; 1993; 9(3):369-82. PubMed ID: 8515140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
